JOINSTAR BIOMEDICAL TECHNOLOGY MA AACC CHICAGO 2022

AACC2022

Wahi Hale Pahu763 

Kikako26-28Iulai 2022

JOINSTAR BIOMEDICAL TECHNOLOGYCO.LTD., hauʻoli e hoʻolaha i ko mākou komo ʻana ma kaAACCHōʻikeʻike ma Kikako keia makahiki.

E hauʻoli mākou i ka hui ʻana me ʻoe ma ko mākou hale keʻena inā ʻoe e hoʻolālā e hele i ka hōʻikeʻike o kēia makahiki.

JOINSTARisʻO kekahi o nā mea hana alakaʻi Point-of-Care ma Kina me ka ʻoi aku o 25 assays e pili ana i ka ʻenehana assay Dry Immunofluorescence.ʻO kā mākou waihona huahana nui e uhi i nā wahi maʻi e like me Infection maʻis, Cardiovascular, ʻO ka maʻi kīpē, ke olakino hānau etc. ʻO Joinstar ka mea holo mua ma ka hoʻokele ʻana o Sepsis me ka loaʻa ʻana o kahi hōʻike POCT no kahi biomarker patented novel, Heparin Binding Protein (HBP).Ua hōʻike ʻia kēia biomarker hou i kahi hōʻailona prognostic maikaʻi aʻe i ka sepsis i hoʻohālikelike ʻia i nā hoʻokolohua maʻamau i kēia manawa.Ma kahi o HBP, ʻo Joinstar wale nō ka hui e hoʻokomo i kahi panel Sepsis piha i kāna repertoire, me nā hoʻokolohua no PCT a me IL-6.I ka wā o ka maʻi maʻi Covid 19 i kēia manawa, ua hōʻike ʻia kēia mau assays, ʻoi aku hoʻi ʻo HBP, i mea nui i ka hoʻokele maʻi a me nā ʻikepili hou mai kekahi mau paʻi.Hiki i ka HBP ke wānana i ka hāʻule ʻana o ka hanu a me 28 mau lā make i nā maʻi maʻi COVID-19a oia no hoiankumu pilikia kūʻokoʻa no ka make)   

No ka 'ike hou aku, e leka uilauspololei a kipa paha i kā mākou pūnaewele: https://www.joinstar.com/jet-istar-platform/

no ka ʻike pili, e ʻoluʻoluleka uila iā:info@joinstar.cn- we kakali i ka lohe mai iā ʻoe, a me ka manaʻolana e ʻike iā ʻoe ma Chicago!E hele mai e ʻike iā mākou, ma ka hui Joinstar#763a e aʻo i nā mea a pau e pili ana i kā mākou ʻano huahana a me nā mea kani.


Ka manawa hoʻouna: Iune-20-2022